PRICE T ROWE ASSOCIATES INC /MD/ - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 47 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$113,000
-38.6%
17,400
-22.3%
0.00%
Q1 2021$184,000
+12.9%
22,400
+61.2%
0.00%
Q4 2020$163,00013,9000.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$16,344,0002.72%
Ikarian Capital, LLC 2,716,840$17,631,0001.42%
Telemetry Investments, L.L.C. 40,000$260,0000.36%
ACT CAPITAL MANAGEMENT, LLC 28,500$185,0000.10%
Vigilare Wealth Management 17,000$110,0000.07%
X-Square Capital, LLC 20,973$136,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 294,031$1,908,0000.06%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$545,0000.06%
NEA Management Company, LLC 346,718$2,250,0000.03%
GSA CAPITAL PARTNERS LLP 36,370$236,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders